H.C. Wainwright Liver Disease Virtual Conference – October 21-22, 2025
Presentation available on demand beginning October 21 at 7:00 am ET and virtual 1x1s on October 22
ProQR shared additional analyses from the Phase 2/3 Illuminate trial of sepofarsen for LCA10 and provided an update on the company strategy. Management to host a conference call today at 8:00am EDT (14:00 CET).
This presentation reviews Axiomer editing oligonucleotides (EONs) structure activity, the potential of Axiomer platform as well as its applicability for the treatment of liver originated disorders.
